UCL to harness Synpromics’ promotors in gene therapy collaboration – BioPharma-Reporter.com
BioPharma-Reporter.com |
UCL to harness Synpromics' promotors in gene therapy collaboration
BioPharma-Reporter.com In gene therapy, synthetic promotors – used to regulate gene activity and precisely control protein production – deliver therapeutic genes to immune cells such as microglia, macrophages, and T-cells. Synpromics said the research collaboration provides … |
